BioSpace News Archive

The Thought Leadership & Innovation Foundation announces plans to build on its existing Regenerative Medicine Program through a research collaboration with cellular therapy industry leader RenovaCare.

Imonti is passionate about supporting the organization’s mission to add years of health and well-being to the lives of all Americans.

Annihilare CEO Marty Paris explains “our system provides unmatched results in disinfection by using the most effective fluids with the most effective cleaning protocols.”

Two inventors, from Lancaster, Calif., wanted to create a safe and secure way to walk or rest when using a walker, so they invented the HOPE SAFETY WALKER.

Applied Medical Technology, Inc. (AMT) announced that it has expanded its ColoCare™ product offering to include a 10F MiniACE® Low Profile Antegrade Continence Enema Button.

UFC GYM®, the rapidly expanding fitness franchise that creates training programs for all levels and ages inspired by the regimens of UFC® athletes, is excited to announce its partnership with NormaTec, the industry leader in compression recovery technology

IRIDEX Corporation announced the appointment of Robert Gunst as Chairman of the Board, effective October 23, 2019. Concurrent with this appointment, Ruediger Naumann-Etienne departed from the Board of Directors as Lead Independent Director.

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its third quarter 2019 financial results and provide a business update on Monday, November 4, 2019 prior to open of the U.S. financial markets.

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients with significant unmet medical need, today reported third quarter 2019 financial results and highlighted recent corporate and pipeline activity.

Profound Medical Corp. (TSX:PRN; OTCQX:PRFMD) (“Profound” or the “Company”) today announced that The Nasdaq Stock Market LLC (“Nasdaq”) has certified the Company’s common shares for listing on the Nasdaq Capital Market.